There are very scarce data about transplant outcomes in patients with Philadelphia chromosome–like B ALL; therefore, the EBMT and ASTCT have no clear indications for HCT in patients with Philadelphia chromosome–like B ALL in CR1. There are multiple factors that can affect the decision on...